tiprankstipranks
Advertisement
Advertisement

AU:CYP Stock Latest News

Cynata Options Expire Unexercised, Streamlining Capital Structure
Company AnnouncementsCynata Options Expire Unexercised, Streamlining Capital Structure
6d ago
Cynata Reaches Key Phase 2 Milestone in aGvHD as Late-Stage Cell Therapy Pipeline Advances
PremiumCompany Announcements
Cynata Reaches Key Phase 2 Milestone in aGvHD as Late-Stage Cell Therapy Pipeline Advances
14d ago
Cynata Narrows Half-Year Loss but Faces Going Concern Uncertainty
PremiumCompany Announcements
Cynata Narrows Half-Year Loss but Faces Going Concern Uncertainty
2M ago
Cynata to Host Investor Webinar and Expand Online Engagement With Shareholders
PremiumCompany Announcements
Cynata to Host Investor Webinar and Expand Online Engagement With Shareholders
2M ago
Cynata Nears Key Data Readouts as Pivotal Cell Therapy Trials Advance
PremiumCompany Announcements
Cynata Nears Key Data Readouts as Pivotal Cell Therapy Trials Advance
2M ago
Cynata Raises $1.2m via At-The-Market Facility to Support Cell Therapy Pipeline
PremiumCompany AnnouncementsCynata Raises $1.2m via At-The-Market Facility to Support Cell Therapy Pipeline
3M ago
Cynata Completes Enrollment in Phase 2 aGvHD Trial
Premium
Company Announcements
Cynata Completes Enrollment in Phase 2 aGvHD Trial
4M ago
Cynata’s CYP-001 Therapy Shows Promise in Kidney Transplant Trial
Premium
Company Announcements
Cynata’s CYP-001 Therapy Shows Promise in Kidney Transplant Trial
4M ago
Cynata Therapeutics Updates Director’s Securities Holdings
PremiumCompany Announcements
Cynata Therapeutics Updates Director’s Securities Holdings
4M ago
Cynata Therapeutics Announces Change in Director’s Interest
PremiumCompany Announcements
Cynata Therapeutics Announces Change in Director’s Interest
4M ago
Cynata Therapeutics Announces Change in Director’s Securities Interests
PremiumCompany Announcements
Cynata Therapeutics Announces Change in Director’s Securities Interests
4M ago
Cynata Completes Final Patient Visit in Phase 3 Osteoarthritis Trial
PremiumCompany Announcements
Cynata Completes Final Patient Visit in Phase 3 Osteoarthritis Trial
5M ago
Cynata Therapeutics Unveils Updated Investor Presentation
PremiumCompany AnnouncementsCynata Therapeutics Unveils Updated Investor Presentation
5M ago
Cynata Therapeutics Passes Key Resolutions at Annual General Meeting
Premium
Company Announcements
Cynata Therapeutics Passes Key Resolutions at Annual General Meeting
5M ago
Cynata Therapeutics Hosts Investor Webinar to Update on Key Projects
Premium
Company Announcements
Cynata Therapeutics Hosts Investor Webinar to Update on Key Projects
5M ago
Cynata Therapeutics Secures $1.7 Million R&D Tax Refund to Boost Cell Therapy Development
PremiumCompany Announcements
Cynata Therapeutics Secures $1.7 Million R&D Tax Refund to Boost Cell Therapy Development
5M ago
Cynata Therapeutics Approaches Key Clinical Milestones with Promising Trials
PremiumCompany Announcements
Cynata Therapeutics Approaches Key Clinical Milestones with Promising Trials
5M ago
Cynata Therapeutics Announces Cessation of Securities
PremiumCompany Announcements
Cynata Therapeutics Announces Cessation of Securities
6M ago
Cynata Therapeutics Announces 2025 AGM Details
PremiumCompany Announcements
Cynata Therapeutics Announces 2025 AGM Details
6M ago
Cynata Therapeutics Schedules AGM and Opens Director Nominations
PremiumCompany AnnouncementsCynata Therapeutics Schedules AGM and Opens Director Nominations
7M ago
Cynata Therapeutics Releases Updated Corporate Governance Statement
Premium
Company Announcements
Cynata Therapeutics Releases Updated Corporate Governance Statement
8M ago
Cynata Therapeutics Advances Clinical Trials Amid Financial Losses
Premium
Company Announcements
Cynata Therapeutics Advances Clinical Trials Amid Financial Losses
8M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >